ranimustine has been researched along with prednisone in 18 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (16.67) | 18.2507 |
2000's | 10 (55.56) | 29.6817 |
2010's | 3 (16.67) | 24.3611 |
2020's | 2 (11.11) | 2.80 |
Authors | Studies |
---|---|
Togawa, A | 1 |
Araki, K; Arima, N; Chiyoda, S; Hosokawa, T; Ikeda, S; Kawano, F; Kikuchi, H; Kinoshita, KI; Kohno, H; Matsuzaki, H; Miyoshi, I; Momita, S; Nishimura, H; Taguchi, H; Takahashi, H; Takatsuki, K; Tamura, K; Tomonaga, M; Tsuda, H; Uozumi, K; Yamada, O | 1 |
Hirabayashi, N; Hotta, T; Ichikawa, A; Kamiya, O; Kato, R; Kato, Y; Kawashima, K; Kobayashi, M; Mizuno, H; Nagura, E; Naito, K; Nishiwaki, H; Nitta, M; Saito, H; Shibata, T; Shimizu, K; Takeyama, H; Tanaka, M; Utsumi, M | 1 |
Aoyama, Y; Hino, M; Kamitani, T; Kishida, T; Koh, KR; Mugitani, A; Nakamae, H; Ohta, K; Ota, T; Sannomiya, Y; Takubo, T; Tatsumi, N; Yamane, T | 1 |
Sakai, C; Takagi, T; Tamaru, J; Tsujimura, H | 1 |
Araki, K; Fukuda, H; Hanada, S; Hotta, T; Ikeda, S; Kawano, F; Kozuru, M; Niimi, M; Sano, M; Shimoyama, M; Takatsuki, K; Tara, M; Tobinai, K; Tomonaga, M; Utsunomiya, A; Yamada, Y | 1 |
Kobayashi, K; Matano, S; Minouchi, K; Ohta, H; Sanada, T; Sugimoto, T | 1 |
Ichikawa, A; Kamiya, O; Kawashima, K; Kobayashi, M; Mizuno, H; Nagura, E; Nitta, M; Saito, H; Shimizu, K; Takeyama, H; Wakita, A; Yamao, H | 1 |
Chou, T; Deura, K; Hirano, M; Hotta, T; Itoh, K; Kawano, K; Konda, S; Matsuda, S; Mikuni, C; Mizorogi, F; Nagoshi, H; Ohno, T; Sai, T; Sano, M; Shimoyama, M; Suzuki, T; Takenaka, T; Tomonaga, M; Tsushita, K; Utsunomiya, A; Yamada, T | 1 |
Hasegawa, H; Miyagi, T; Nagasaki, A; Nakachi, S; Shinzato, O; Taira, N; Takasu, N; Tomoyose, T | 1 |
Fujimoto, Y; Ishihara, S; Izumi, H; Kaneko, K; Kato, M; Kuraishi, Y; Nagase, D; Natori, K; Umeda, M | 1 |
Fukuda, H; Fukushima, T; Hanada, S; Hotta, T; Ikeda, S; Kawano, F; Masuda, M; Momita, S; Nagoshi, H; Sano, M; Shibata, T; Shimoyama, M; Takatsuka, Y; Tamura, K; Tobinai, K; Tomonaga, M; Tsukasaki, K; Ueda, R; Utsunomiya, A; Yamaguchi, K | 1 |
Fujigaki, H; Hoshi, M; Ito, H; Ohtaki, H; Ohyama, M; Saito, K; Seishima, M; Takahashi, T; Takemura, M; Tanaka, R; Tomita, E | 1 |
Ishigaki, T; Kobayashi, M; Kobayashi, S; Ohno, N; Sato, K; Tojo, A; Uchimaru, K; Watanabe, N; Yuji, K | 1 |
Miyahara, M; Ureshino, H | 1 |
Ishida, T; Ogura, M; Takahashi, T; Tsukasaki, K; Utsunomiya, A | 1 |
Amano, M; Imaizumi, Y; Ishida, T; Ishitsuka, K; Ishizawa, K; Ito, S; Iwanaga, M; Nosaka, K; Ohshima, K; Tanaka, J; Tobinai, K; Tokura, Y; Tsukasaki, K; Uchimaru, K; Uike, N; Utsunomiya, A; Watanabe, T | 1 |
Iida, S; Inagaki, H; Ishida, T; Ito, A; Iwasaki, H; Kusumoto, S; Masaki, A; Murase, T; Muto, R; Nakano, N; Sakamoto, Y; Takeshita, M; Tashiro, Y; Tokunaga, M; Ueda, R; Utsunomiya, A; Yonekura, K | 1 |
6 trial(s) available for ranimustine and prednisone
Article | Year |
---|---|
An intensive chemotherapy of adult T-cell leukemia/lymphoma: CHOP followed by etoposide, vindesine, ranimustine, and mitoxantrone with granulocyte colony-stimulating factor support.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Bone Marrow; Cyclophosphamide; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Mitoxantrone; Nitrosourea Compounds; Prednisone; Vincristine; Vindesine | 1996 |
A randomized study comparing VMCP and MMPP in the treatment of multiple myeloma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Humans; Melphalan; Middle Aged; Multiple Myeloma; Nitrosourea Compounds; Prednisolone; Prednisone; Procarbazine; Vincristine | 1997 |
[High-dose chemotherapy with autologous peripheral blood stem cell transplantation for treatment of non-Hodgkin's lymphoma].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nitrosourea Compounds; Prednisone; Survival Rate; Vincristine | 2000 |
A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Nitrosourea Compounds; Prednisone; Survival Rate; Time Factors; Vincristine; Vindesine | 2001 |
Phase III study of ranimustine, cyclophosphamide, vincristine, melphalan, and prednisolone (MCNU-COP/MP) versus modified COP/MP in multiple myeloma: a Japan clinical oncology group study, JCOG 9301.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Female; Humans; Japan; Male; Melphalan; Middle Aged; Multiple Myeloma; Nitrosourea Compounds; Prednisone; Treatment Outcome; Vincristine | 2004 |
VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Nitrosourea Compounds; Prednisone; Survival Rate; Vincristine | 2007 |
12 other study(ies) available for ranimustine and prednisone
Article | Year |
---|---|
[Recent therapy for refractory myeloma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclophosphamide; Dexamethasone; Doxorubicin; Drug Administration Schedule; Female; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Nitrosourea Compounds; Podophyllotoxin; Prednisone; Remission Induction; Survival Rate; Vincristine | 1993 |
Involvement of the appendix in a relapsed case of primary nasal NK/T-cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Appendectomy; Appendiceal Neoplasms; Appendicitis; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Epstein-Barr Virus Infections; Etoposide; Humans; Intestinal Perforation; Killer Cells, Natural; Leucovorin; Lymphoma, T-Cell; Male; Methotrexate; Methylprednisolone; Nitrosourea Compounds; Nose Neoplasms; Prednisone; Skin Neoplasms; Splenic Neoplasms; Tumor Virus Infections; Vincristine | 2000 |
Prophylactic effect of interferon-alpha for exacerbation of hepatitis B after high-dose chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Cyclophosphamide; DNA, Viral; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Hepatitis B, Chronic; Humans; Interferon-alpha; Liver Function Tests; Lymphoma, B-Cell; Male; Nitrosourea Compounds; Prednisone; Radiotherapy, Adjuvant; Remission Induction; Salvage Therapy; Transplantation, Autologous; Vincristine; Viremia; Virus Activation | 2001 |
Superior efficacy of MMCP regimen compared with VMCP and MMPP regimens in the treatment of multiple myeloma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Nitrosourea Compounds; Prednisolone; Prednisone; Procarbazine; Remission Induction; Survival Rate; Treatment Outcome; Vincristine | 2002 |
[Development of acute type, CD 8 positive adult T-cell leukemia in a carrier of hepatitis B virus--possible therapeutic effect of lamivudine combined with chemotherapy].
Topics: Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carrier State; CD8-Positive T-Lymphocytes; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Hepatitis B; HTLV-I Antibodies; Humans; Irinotecan; Lamivudine; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Mitoxantrone; Nitrosourea Compounds; Pentostatin; Prednisone; Vincristine | 2006 |
[Four cases of therapy-related leukemia in multiple myeloma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Humans; Leukemia, Myeloid, Acute; Male; Melphalan; Middle Aged; Multiple Myeloma; Neoplasms, Second Primary; Nitrosourea Compounds; Prednisolone; Prednisone; Vincristine | 2007 |
Changes in serum tryptophan catabolism as an indicator of disease activity in adult T-cell leukemia/lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Drug Monitoring; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; Leukemia-Lymphoma, Adult T-Cell; Metabolic Networks and Pathways; Neoplasm Proteins; Neoplastic Cells, Circulating; Neutropenia; Nitrosourea Compounds; Prednisone; Receptors, Interleukin-2; Tryptophan; Tryptophan Oxygenase; Vincristine; Vindesine | 2009 |
Loss of CCR4 antigen expression after mogamulizumab therapy in a case of adult T-cell leukaemia-lymphoma.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Clone Cells; Cyclophosphamide; Down-Regulation; Doxorubicin; Etoposide; Fatal Outcome; Female; Gene Expression Regulation, Neoplastic; Humans; Leukemia-Lymphoma, Adult T-Cell; Middle Aged; Neoplasm Proteins; Nitrosourea Compounds; Prednisone; Receptors, CCR4; Vincristine; Vindesine | 2013 |
Spontaneous regression of adult T cell leukemia/lymphoma following development of immune thrombocytopenia.
Topics: Adrenal Cortex Hormones; Allografts; Antineoplastic Combined Chemotherapy Protocols; Benzoates; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Hydrazines; Leukemia-Lymphoma, Adult T-Cell; Middle Aged; Nitrosourea Compounds; Prednisolone; Prednisone; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Remission, Spontaneous; Vincristine; Vindesine | 2016 |
Effects of first-line chemotherapy on natural killer cells in adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Case-Control Studies; Cyclophosphamide; Doxorubicin; Etoposide; Female; Flow Cytometry; Humans; Killer Cells, Natural; Leukemia-Lymphoma, Adult T-Cell; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Nitrosourea Compounds; Prednisone; Vincristine; Vindesine | 2016 |
Prognosis of patients with adult T-cell leukemia/lymphoma in Japan: A nationwide hospital-based study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cause of Death; Cyclophosphamide; Doxorubicin; Female; Health Care Surveys; Hematopoietic Stem Cell Transplantation; Hospitals; Humans; Japan; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Nitrosourea Compounds; Prednisone; Prognosis; Retrospective Studies; Survival Rate; Vincristine; Vindesine | 2020 |
Clinical significance of TP53 mutations in adult T-cell leukemia/lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Allografts; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; CD28 Antigens; Cyclophosphamide; DNA Copy Number Variations; Doxorubicin; Etoposide; Female; Genes, p53; Hematopoietic Stem Cell Transplantation; Humans; INDEL Mutation; Kaplan-Meier Estimate; Lenalidomide; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Mutation; Nitrosourea Compounds; Polymorphism, Single Nucleotide; Prednisolone; Prednisone; Prognosis; Receptors, CCR4; Vincristine; Vindesine | 2021 |